Kathryn Stephenson, MD, MPH (Center for Virology & Vaccine Research, BIDMC) discusses the recent call for the creation of an independent commission separate from the FDA to review data from coronavirus vaccine trials.
Kathryn Stephenson, MD, MPH (Center for Virology & Vaccine Research, BIDMC) discusses the recent call for the creation of an independent commission separate from the FDA to review data from coronavirus vaccine trials.
Known as “long-haulers,” these patients call for more research, especially in the Boston area.
John Torous, MD (Psychiatry, BIDMC) discusses the rise of digital medicine during the COVID-19 pandemic.
Researchers at BIDMC and Harvard TH Chan School of Public Health quantified COVID-19′s disproportionate toll on Black and Latinx communities in Massachusetts and explored the extent to which other demographic factors explain racial and ethnic gaps.
The pandemic produced a ’perfect storm’ of factors for communities of color.
Alexa B. Kimball, MD, MPH (President & CEO, Harvard Medical Faculty Physicians at BIDMC) and other healthcare professionals put together a checklist of what Massachusetts still needs to prepare for a potential second surge of COVID-19 cases.
Alexa B. Kimball, MD, MPH (President & CEO, Harvard Medical Faculty Physicians at BIDMC) discusses how hospitals are preparing for a potential second surge of COVID-19, and why colder months present more of a challenge in terms of social distancing.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses how we might develop immunity to COVID-19, noting that it would take time.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses the first documented case of COVID-19 reinfection.
C. Michael Gibson (Cardiology, BIDMC) discusses the FDA issuing an emergency use authorization of convalescent plasma for the treatment of COVID-19.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses “Operation Warp Speed” which has allocated nearly $11 billion to pharmaceutical companies to accelerate the discovery and production of a COVID-19 vaccine.
Russia's plan to roll-out a COVID-19 vaccine before full trial results is prompting concern among virus experts, who warn a partially effective shot may encourage the novel coronavirus to mutate. Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) notes that mutation rates for COVID-19 are far lower than viruses like HIV, but there are downsides to using a vaccine that doesn’t work.
As patients avoided hospitals and doctors’ offices, conditions like cancer and heart disease went untreated. Health care providers now stress the importance of non-COVID-19 care as the pandemic stretches on.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses the timeline and process of developing a vaccine.
Kevin Tabb, MD (CEO & President, BILH) participated in the “Fireside Chat” podcast with Gary Bisbee to discuss Beth Israel Lahey Health, the impact that COVID-19 has had on telehealth services, and leading a health system during a crisis.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses the COVID-19 outbreak in New Zealand and why cases are so hard to detect due to asymptomatic cases and spread.
But many scientists consider human challenge trials with the coronavirus unethical because there are no "rescue therapies" for those who fall ill.
John Torous, MD (Psychiatry, BIDMC) and colleagues report in Psychiatric Services that college students waiting for mental health services are often directed off-campus or to mobile apps for care.
